Miransertib (ARQ 092) HCl
CAS:
Ref. 3D-NCC88300
10mg
332.00€
25mg
465.00€
50mg
623.00€
100mg
791.00€
250mg
1,272.00€
Product Information
Name:Miransertib (ARQ 092) HCl
Brand:Biosynth
Description:Miransertib (ARQ 092) HCl is a selective inhibitor, which is a synthetic small molecule specifically targeting the AKT pathway. It is sourced through specialized chemical synthesis designed to interfere with key signaling pathways implicated in the proliferation and survival of cancer cells. The mode of action involves the inhibition of the serine/threonine kinase AKT, an integral part of the PI3K/AKT/mTOR signaling pathway that is frequently dysregulated in various cancers.
Miransertib's ability to inhibit AKT disrupts aberrant signaling cascades, leading to the suppression of cancer cell growth and induction of apoptosis. Its primary uses and applications are in the therapeutic investigation of disorders such as Proteus syndrome, PIK3CA-related overgrowth spectrum (PROS), and situations where AKT pathway activation contributes to oncogenesis. Current research includes clinical trials focusing on its efficacy and safety profile to better understand its potential as a targeted cancer therapy.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:468.98 g/mol
Formula:C27H25ClN6
Purity:Min. 95%
Technical inquiry about: Miransertib (ARQ 092) HCl
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.